Impact of the COVID-19 Pandemic on Obesity, Metabolic Parameters and Clinical Values in the South Korean Adult Population.
Anna KimEun-Yeob KimJae Young KimPublished in: Journal of clinical medicine (2024)
This study aimed to evaluate the effects of the COVID-19 pandemic on obesity, metabolic parameters, and clinical values in the South Korean population. Data from the seventh and eighth National Health and Nutrition Examination Surveys were analyzed, comprising 3560 participants in 2018 (pre-COVID-19) and 3309 participants in 2021 (post-COVID-19). The study focused on adults aged 19 years and older who were overweight (BMI ≥ 25 kg/m 2 ). The results showed a significant increase in waist circumference (approximately 2 cm), BMI (approximately 0.11 kg/m 2 ), systolic blood pressure, fasting blood sugar (1.76 mg/dL higher), and glycated hemoglobin (0.14% higher) in the post-COVID-19 group compared to the pre-COVID-19 group. Additionally, the prevalence of hypercholesterolemia increased by 4% after the COVID-19 pandemic. These findings suggest an increased risk of obesity, abdominal obesity, and metabolic disorders, such as blood sugar disorders, in the post-COVID-19 period. Urine analysis revealed abnormal findings, including occult blood, urobilinogen, hematuria, proteinuria, ketone urea, glycosuria, and bacteriuria. The study highlights the negative impact of lifestyle changes, such as reduced physical activity and social gatherings, on physical vital signs and clinical values during the COVID-19 pandemic.
Keyphrases
- physical activity
- coronavirus disease
- sars cov
- weight loss
- body mass index
- weight gain
- insulin resistance
- metabolic syndrome
- blood pressure
- type diabetes
- high fat diet induced
- cardiovascular disease
- heart failure
- respiratory syndrome coronavirus
- adipose tissue
- risk factors
- left ventricular
- heart rate
- hypertensive patients
- deep learning
- body weight
- blood glucose
- single cell
- artificial intelligence
- red blood cell